In the BioHarmony Drug Report Database

"Preview" Icon

Halobetasol

Bryhali, Lexette, Ultravate (halobetasol) is a small molecule pharmaceutical. Halobetasol was first approved as Bryhali on 1990-12-17. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses amongst others in the USA. Halobetasol propionate’s patents are valid until 2036-11-30 (FDA).

 

Trade Name

 

Bryhali, Lexette, Ultravate
 

Common Name

 

halobetasol
 

ChEMBL ID

 

CHEMBL1201360
 

Indication

 

facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, pruritus, scalp dermatoses
 

Drug Class

 

Image (chem structure or protein)

Halobetasol structure rendering